Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Sposto

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Pediatric Hematology and Oncology|April 28, 2020
A phase I study of panobinostat in children with relapsed and refractory hematologic malignanciesJohn Goldberg, Maria Luisa Sulis, Julia Bender, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer GroupMark T Jennings, Richard Sposto, James M Boyett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2017
Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and PrognosisAraz Marachelian, Judith G Villablanca, Cathy W Liu, et al.
Neuro-Oncology|April 19, 2020
Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trialGirish Dhall, Sharon H O'Neil, Lingyun Ji, et al.
Pediatric Blood & Cancer|August 22, 2022
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR)James A Whitlock, Jemily Malvar, Luciano Dalla-Pozza, et al.
Pediatric Blood & Cancer|February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conferenceTerzah M Horton, Richard Sposto, Patrick Brown, et al.
American Journal of Hematology|February 18, 2022
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortiumLauren Pommert, Eric S Schafer, Jemily Malvar, et al.
Leukemia|May 6, 2018
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma studyWeili Sun, Jemily Malvar, Richard Sposto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot StudyMichael J Burke, Rumen Kostadinov, Richard Sposto, et al.
Nature Genetics|January 22, 2013
The genetic landscape of high-risk neuroblastomaTrevor J Pugh, Olena Morozova, Edward F Attiyeh, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Pediatric Hematology and Oncology|April 28, 2020
A phase I study of panobinostat in children with relapsed and refractory hematologic malignanciesJohn Goldberg, Maria Luisa Sulis, Julia Bender, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer GroupMark T Jennings, Richard Sposto, James M Boyett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2017
Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and PrognosisAraz Marachelian, Judith G Villablanca, Cathy W Liu, et al.
Neuro-Oncology|April 19, 2020
Excellent outcome of young children with nodular desmoplastic medulloblastoma treated on "Head Start" III: a multi-institutional, prospective clinical trialGirish Dhall, Sharon H O'Neil, Lingyun Ji, et al.
Pediatric Blood & Cancer|August 22, 2022
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR)James A Whitlock, Jemily Malvar, Luciano Dalla-Pozza, et al.
Pediatric Blood & Cancer|February 4, 2010
Toxicity assessment of molecularly targeted drugs incorporated into multiagent chemotherapy regimens for pediatric acute lymphocytic leukemia (ALL): review from an international consensus conferenceTerzah M Horton, Richard Sposto, Patrick Brown, et al.
American Journal of Hematology|February 18, 2022
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortiumLauren Pommert, Eric S Schafer, Jemily Malvar, et al.
Leukemia|May 6, 2018
Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma studyWeili Sun, Jemily Malvar, Richard Sposto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2020
Decitabine and Vorinostat with Chemotherapy in Relapsed Pediatric Acute Lymphoblastic Leukemia: A TACL Pilot StudyMichael J Burke, Rumen Kostadinov, Richard Sposto, et al.
Nature Genetics|January 22, 2013
The genetic landscape of high-risk neuroblastomaTrevor J Pugh, Olena Morozova, Edward F Attiyeh, et al.
Pageof 18